Potentiated anticancer effects on hepatoma cells by the retinoid adapalene

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Retinoids are known to inhibit tumor cell proliferation and induce apoptosis.
• Hepatocellular carcinoma (HCC) remains a significant global health challenge, necessitating novel therapeutic strategies.

Purpose of the Study:

• To investigate the antitumoral effects of Adapalene (ADA), a synthetic retinoid, on human hepatoma cell lines (HepG2 and Hep1B).
• To elucidate the mechanisms underlying ADA-induced apoptosis and cell growth inhibition in hepatoma cells.

Main Methods:

• Cell proliferation was assessed via DNA synthesis assays.
• Apoptosis was quantified using flow cytometry and immunocytochemistry.
• Western Blotting was employed to analyze apoptosis-related proteins (Bax, Bcl-2, Caspase 3).
• Mitochondrial membrane potential was measured using JC-1 staining.

Main Results:

• Adapalene (10(-4)M) significantly induced apoptosis in HepG2 (61.7%) and Hep1B (79.1%) cells after 72 hours.
• ADA treatment led to the upregulation of pro-apoptotic proteins Bax and Caspase 3, and downregulation of anti-apoptotic protein Bcl-2.
• The Bax/Bcl-2 ratio was significantly increased (>2.3) in ADA-treated hepatoma cells.
• Adapalene treatment disrupted mitochondrial membrane potential, indicating mitochondrial pathway involvement in apoptosis.

Conclusions:

• Adapalene demonstrates significant inhibitory effects on hepatoma cell growth in vitro.
• ADA is a potent inducer of apoptosis in hepatoma cells, acting through modulation of key apoptosis-related proteins and mitochondrial pathways.
• These findings suggest Adapalene as a potential therapeutic agent for hepatocellular carcinoma.